Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.47p
   
  • Change Today:
      0.021p
  • 52 Week High: 3.15
  • 52 Week Low: 0.42
  • Currency: UK Pounds
  • Shares Issued: 374.35m
  • Volume: 2,631,839
  • Market Cap: £1.76m
  • RiskGrade: 435

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
95.88% above the market average95.88% above the market average95.88% above the market average95.88% above the market average95.88% above the market average
93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
67.62% above the market average67.62% above the market average67.62% above the market average67.62% above the market average67.62% above the market average
76.92% above the sector average76.92% above the sector average76.92% above the sector average76.92% above the sector average76.92% above the sector average
Price Book Ratio
77.24% above the market average77.24% above the market average77.24% above the market average77.24% above the market average77.24% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
90.34% below the market average90.34% below the market average90.34% below the market average90.34% below the market average90.34% below the market average
78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average
Price Chg 3m
89.03% below the market average89.03% below the market average89.03% below the market average89.03% below the market average89.03% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
72.42% below the market average72.42% below the market average72.42% below the market average72.42% below the market average72.42% below the market average
80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average
Momentum 20
47.46% below the market average47.46% below the market average47.46% below the market average47.46% below the market average47.46% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
97.66% below the market average97.66% below the market average97.66% below the market average97.66% below the market average97.66% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
60.77% below the market average60.77% below the market average60.77% below the market average60.77% below the market average60.77% below the market average
26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
95.83% below the market average95.83% below the market average95.83% below the market average95.83% below the market average95.83% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average
Operating Profit Loss
57.71% below the market average57.71% below the market average57.71% below the market average57.71% below the market average57.71% below the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
73.81% below the market average73.81% below the market average73.81% below the market average73.81% below the market average73.81% below the market average
54.55% below the sector average54.55% below the sector average54.55% below the sector average54.55% below the sector average54.55% below the sector average
Cash
48.23% below the market average48.23% below the market average48.23% below the market average48.23% below the market average48.23% below the market average
37.78% below the sector average37.78% below the sector average37.78% below the sector average37.78% below the sector average37.78% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.47p
Change Today 0.021p
% Change 4.76 %
52 Week High 3.15
52 Week Low 0.42
Volume 2,631,839
Shares Issued 374.35m
Market Cap £1.76m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.21% above the market average42.21% above the market average42.21% above the market average42.21% above the market average42.21% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Price Trend
95.97% below the market average95.97% below the market average95.97% below the market average95.97% below the market average95.97% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
23.82% above the market average23.82% above the market average23.82% above the market average23.82% above the market average23.82% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

Valirx Dividends

No dividends found

Trades for 12-Jun-2025

Time Volume / Share Price
14:18 500,000 @ 0.49p
14:18 500,000 @ 0.48p
14:06 528,982 @ 0.44p
11:05 500,000 @ 0.49p
11:04 500,000 @ 0.49p

Valirx Key Personnel

CFO Gerald Desler

Top of Page